Interim results of a phase II randomized study of lapatinib (GW572016) as first-line treatment for patients with FISH-amplified advanced or metastatic breast cancer

被引：0
作者：
Stein, S. H.
Gomez, H. L.
Chavez, M. A.
Doval, D. C.
Chow, L. W.
Newstat, B.
Berger, M. S.
Sledge, G. W.
机构：
[1] GlaxoSmithKline Inc, Med Dev Ctr Oncol, Collegeville, MN USA
[2] Inst Special Enfermedades Neoplasica, Lima, Peru
[3] Hosp Alberto Sabogal, Lima, Peru
[4] Rajiv Gandhi Canc Inst, Res Ctr, New Delhi, India
[5] Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China
[6] Indiana Univ, Indianapolis, IN 46204 USA
来源：
EJC SUPPLEMENTS | 2005年 / 3卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：78 / 78
页数：1
相关论文
共 50 条
[41]   Phase II study of Taxotere in advanced or/and metastatic breast cancer as a first or second line of treatment [J].
Borisova, TA ;
Orel, NF ;
Pirogova, NA ;
Gorbounova, VA .
ANNALS OF ONCOLOGY, 1998, 9 :28-28
[42]   A Phase II study of gefitinib combined with docetaxel as first-line treatment in patients with advanced breast cancer. [J].
Ciardiello, F ;
Troiani, T ;
Caputo, F ;
De Laurentiis, M ;
Palmieri, G ;
Marinelli, A ;
Colantuoni, G ;
Diadema, MR ;
De Placido, S ;
Bianco, AR .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) :58S-58S
[43]   Phase Ib study of sorafenib and vinorelbine as first-line treatment in patients with metastatic breast cancer [J].
Ferrario, C. ;
Charamis, H. ;
Oyewole-Eletu, S. ;
Mihalcioiu, C. L. ;
Langleben, A. ;
Miller, W. H. ;
Aloyz, R. ;
Panasci, L. C. .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[44]   A phase II trial of capecitabine and vinorelbine as first-line treatment in patients with metastatic breast cancer (BC) [J].
Palumbo, Raffaella ;
Bernardo, Antonio ;
Strada, Maria Rosa ;
Poggi, Guido ;
Delmonte, Angelo ;
Teragni, Cristina ;
Frascaroli, Mara ;
Bernardo, Giovanni .
ANNALS OF ONCOLOGY, 2006, 17 :75-75
[45]   Phase II Multicenter Study of Docetaxel and Bevacizumab With or Without Trastuzumab as First-Line Treatment for Patients With Metastatic Breast Cancer [J].
Schwartzberg, Lee S. ;
Badarinath, Suprith ;
Keaton, Mark R. ;
Childs, Barrett H. .
CLINICAL BREAST CANCER, 2014, 14 (03) :161-168
[46]   First-line paclitaxel and cisplatin used sequentially or in combination in metastatic breast cancer: A phase II randomized study [J].
Elserafi, Mostafa M. ;
Zeeneldin, Ahmed A. ;
Abdelsalam, Ibrahim M. ;
Nassar, Hanan R. ;
Moneer, Manar M. ;
Buhoush, Wafa H. .
JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE, 2018, 30 (01) :13-20
[47]   Gemcitabine as first-line therapy in patients with metastatic breast cancer: A phase II trial [J].
Blackstein, M ;
Vogel, CL ;
Ambinder, R ;
Cowan, J ;
Iglesias, J ;
Melemed, A .
ONCOLOGY, 2002, 62 (01) :2-8
[48]   Letrozole (LE)-Vinorelbine (VIN) as first-line treatment in advanced breast cancer (ABC) patients: Preliminary results of a multicentre Phase II study [J].
Barni, S. ;
Colina, P. ;
Leo, S. ;
Sandri, P. ;
Savarino, A. ;
Pollera, F. ;
Ardizzoia, A. ;
Barberis, G. ;
Mari, Di ;
Cazzaniga, M. .
EJC SUPPLEMENTS, 2004, 2 (03) :129-129
[49]   Palbociclib in combination with letrozole as first-line treatment for advanced breast cancer: A Japanese phase II study [J].
Masuda, Norikazu ;
Nishimura, Reiki ;
Takahashi, Masato ;
Inoue, Kenichi ;
Ohno, Shinji ;
Iwata, Hiroji ;
Mori, Yuko ;
Hashigaki, Satoshi ;
Muramatsu, Yasuaki ;
Nagasawa, Takashi ;
Umeyama, Yoshiko ;
Toi, Masakazu .
CANCER SCIENCE, 2018, 109 (03) :803-813
[50]   Biomarker analysis of lapatinib with paclitaxel versus paclitaxel as first-line treatment in 580 patients with metastatic breast cancer [J].
Finn, R. S. ;
Press, M. F. ;
Dering, J. ;
Gomez, H. ;
Aziz, Z. ;
Arbushites, M. ;
Koehler, M. ;
Oliva, C. ;
Williams, L. S. ;
Di Leo, A. .
EJC SUPPLEMENTS, 2007, 5 (04) :212-212
12345